Asensus Surgical Inc. (ASXC): Price and Financial Metrics


Asensus Surgical Inc. (ASXC): $2.34

0.04 (+1.74%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ASXC Stock Price Chart Interactive Chart >

Price chart for ASXC

ASXC Price/Volume Stats

Current price $2.34 52-week high $6.95
Prev. close $2.30 52-week low $0.32
Day low $2.26 Volume 2,715,100
Day high $2.38 Avg. volume 20,469,674
50-day MA $2.76 Dividend yield N/A
200-day MA $2.29 Market Cap 545.66M

Asensus Surgical Inc. (ASXC) Company Bio


Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.


ASXC Latest News Stream


Event/Time News Detail
Loading, please wait...

ASXC Latest Social Stream


Loading social stream, please wait...

View Full ASXC Social Stream

Latest ASXC News From Around the Web

Below are the latest news stories about Asensus Surgical Inc that investors may wish to consider to help them evaluate ASXC as an investment opportunity.

Asensus Surgical Receives FDA 510(k) Clearance for Articulating Instruments

RESEARCH TRIANGLE PARK, N.C., July 28, 2021--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that it has received FDA 510(k) clearance for 5 mm diameter articulating instruments, adding to the Senhance Surgical System technology platform. Articulating instruments offer better access to difficult-to-reach areas of the anatomy by providing two

Yahoo | July 28, 2021

Asensus Surgical Announces the Appointment of Two New Board Members

RESEARCH TRIANGLE PARK, N.C., July 26, 2021--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing two new board members, Elizabeth Kwo, MD and Kevin Hobert, effective immediately.

Yahoo | July 26, 2021

Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 5, 2021

RESEARCH TRIANGLE PARK, N.C., July 22, 2021--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 second quarter financial and operating results after the market closes on Thursday, August 5, 2021. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be

Yahoo | July 22, 2021

Asensus Surgical (ASXC) Presents At Ladenburg Thalmann 2021 Virtual Healthcare Conference - Slideshow

The following slide deck was published by Asensus Surgical, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | July 16, 2021

Asensus Surgical files 510(k) submission to FDA for expansion of machine vision capabilities

Asensus Surgical (ASXC) has filed a 510(k) submission with the FDA for an expansion of capabilities on the previously cleared Intelligent Surgical Unit ((ISU)).The ISU is utilized on the Company’s Senhance Surgical System which enables digital laparoscopy. The current features of the ISU enable machine vision driven control of the...

Seeking Alpha | July 14, 2021

Read More 'ASXC' Stories Here

ASXC Price Returns

1-mo -19.03%
3-mo 19.39%
6-mo -32.17%
1-year 379.12%
3-year N/A
5-year N/A
YTD 274.40%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6488 seconds.